AI-generated summary
The authors used human synovial and chondrocyte cell lines treated with TNF-α, plus hTNF-α transgenic mice, to test 630 nm LED photobiomodulation. They report that the light reduced TNF-α-induced expression of several inflammatory and senescence-associated markers, and partly restored mitochondrial-related markers. Findings come from cell and animal models, not human patients.
- Who or what was studied
- Human fibroblast-like synoviocyte (MH7A) and chondrocyte (C28/I2) cell lines, and hTNF-α transgenic mice
- Wavelengths
- 630 nm
- Limits stated in the abstract
- The study uses cell lines and transgenic mice rather than human participants, and the abstract does not report a participant count.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on mdpi.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 630 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Light-emitting diode, Photobiomodulation, Reactive oxygen species, Oxidative stress, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.